Investors Don't See Light At End Of Amylyx Pharmaceuticals, Inc.'s (NASDAQ:AMLX) Tunnel And Push Stock Down 26%

Simply Wall StDec 19 14:15 ET

Selling Amylyx Pharmaceuticals Shares at a Lower Price Than Current Market Value May Have Been a Costly Mistake for Insiders

Simply Wall StDec 11 07:03 ET

BofA Securities Maintains Amylyx Pharmaceuticals(AMLX.US) With Buy Rating, Announces Target Price $10

Moomoo NewsDec 5 12:31 ET · Ratings

H.C. Wainwright Maintains Amylyx Pharmaceuticals(AMLX.US) With Buy Rating, Maintains Target Price $12

Moomoo NewsDec 5 12:31 ET · Ratings

Express News | HC Wainwright & Co. Reiterates Buy on Amylyx Pharma, Maintains $12 Price Target

BenzingaDec 5 07:07 ET

Express News | Amylyx Pharmaceuticals Shares up 1.7% on Late-Stage Trial Update for Low-Blood Sugar Drug

ReutersDec 4 09:50 ET